Most people support affordable housing in principle. Ask whether it should go on their block, and the answer often changes. Support for a policy or action in the abstract typically weakens when it becomes personal, proximate, and specific. The phenomenon is so consistent it has a name: NIMBY — Not In My Backyard.
Utilization management (UM) is an attempt to solve a real problem: how to provide good care to many people without making coverage unaffordable. Its restrictions are designed to promote evidence-based care and responsible use of shared resources. But when a specific coverage request is denied, delayed, or conditioned, the response from patients, caregivers, and clinicians is often intense.
That gap — between supporting UM in principle and experiencing a specific denial as a personal event, sometimes a high-stakes one — is the NIMBY problem in health care. Sometimes the concern is entirely legitimate: unreasonable delay, unclear reasoning, or a decision that does not seem well grounded in evidence. But even when UM is rational, the response to denials is emotional — and predictably so.
Why “no” feels so much worse than “yes”
A UM denial is not only a coverage decision. It is also an experience — one that lands differently for patients, caregivers, and clinicians than it appears in policy documents or cost models.
Three concepts from behavioral economics and psychology help to explain why UM decisions so often create friction.
1. Denials can feel like something is being taken away
A useful concept from behavioral economics is the endowment effect: People tend to value something more once they perceive it as already theirs. A related idea, loss aversion, means that losses are often felt more strongly than comparable gains.
In health care coverage, many patients do not experience insurance as a tentative possibility (“maybe this will be covered”). They experience it as something they have already paid into and therefore already expect to be available to them through premiums, payroll deductions, cost-sharing, and continued enrollment in the plan. In that frame, a denial is not experienced as a neutral coverage decision; it can feel like a benefit they expected has been taken away. This is not a legal claim that every treatment must be covered; it is a psychological one about how loss is experienced relative to expectation.
2. Restrictions can trigger resistance from clinicians and patients
A second useful concept is psychological reactance. Reactance is the tendency to resist when a person feels that one’s freedom to choose is being constrained.
For clinicians, UM can trigger reactance because it may be experienced as an external party imposing clinical judgment. Even when the underlying issue is a relatively low-cost service or a routine request, the dispute may feel larger than the dollar amount involved. For some clinicians — especially those trained in settings with less front-end utilization review — this can feel like an erosion of long-established professional norms rather than a routine administrative constraint. That may help explain why resistance is sometimes strongest among the most experienced practitioners.
This is not only about ego or professional identity, though that can be part of it. It also reflects ordinary features of clinical practice: Clinicians are accountable for outcomes, must explain delays or denials to patients, and may feel that standardized rules are being substituted for patient-specific judgment.
Reactance can also apply to patients, who often have direct knowledge of their own condition, treatment history, and what works for them — knowledge that may be especially deep with less-common or chronic conditions. A UM restriction can feel like an outside party overriding both medical advice and hard-won personal experience.
Messenger effects can further intensify the conflict. A denial may be less persuasive when it is perceived as coming from someone who is not a true clinical peer for the condition at issue, even if the reviewer is a physician. In practice, disagreement may be driven as much by perceived expertise and legitimacy as by the rule itself.
3. Individual cases overwhelm population logic
A third concept is the identifiable victim effect: People tend to respond more strongly to the needs of a specific, visible person than to abstract statistics about many people.
This matters because UM is designed around population-level tradeoffs. It aims to manage costs and improve consistency across a large group of members. At that level, decisions are often justified using evidence standards, probabilities, and budget impact. But patients, caregivers, and clinicians encounter UM decisions at the individual level.
When the patient is a named person in front of you — not a line in a spreadsheet — the logic changes. For clinicians, the duty to the patient in front of them becomes more salient than savings spread across a population. For patients and caregivers, the issue is not an abstract policy mechanism; it is their pain, function, diagnosis, treatment timeline, and quality of life.
That does not make people hypocrites. It means they are moving between two valid but competing perspectives: the system view, which emphasizes fairness, sustainability, and stewardship of shared resources; and the individual view, which emphasizes immediate care needs, lived experience, and the consequences for one’s health and daily life.
Clinicians often have to operate in both perspectives at once, balancing evidence-based stewardship with a duty to advocate for an individual patient.
Part of what makes this dynamic so persistent is an asymmetry in how certainty is experienced. The plan’s rationale is probabilistic: The evidence standard reflects what tends to work for most patients in a category. But the patient experiences a concrete reality: pain, diagnosis, and treatment. People respond more strongly to visible harm than to equivalent harm expressed statistically. That helps explain why “this approach works for most patients” rarely satisfies someone who believes he or she is the exception — and why that belief is not irrational from the patient’s vantage point.
This tension arises precisely because these perspectives are legitimate and difficult to reconcile in real time.
Saying “no” well
The question is not only whether a decision is clinically justified, evidence-based, and economically rational. It is also whether the decision is communicated and implemented in a way people experience as fair and credible.
Several approaches can help.
1. Reduce unnecessary friction for trusted clinicians and care settings
Gold-carding programs reduce prior authorization requirements for clinicians who consistently follow evidence-based prescribing or ordering patterns. A related idea is granting greater discretion to designated centers of excellence for certain services, where organizations with demonstrated expertise and strong outcomes may be permitted to make appropriate care decisions with less front-end authorization burden.
The practical goal is to reserve intensive review for outlier behavior while reducing burden on clinicians and institutions with strong track records.
Psychologically, gold carding signals that the system can distinguish between routine evidence-based practice and higher-risk exceptions — reducing both the sense of blanket mistrust and repeated autonomy conflicts.
Gold carding and center-of-excellence pathways are not complete solutions. They raise questions about criteria, monitoring, and consistency. But they can reduce conflict where the cost of review is higher than the likely benefit.
2. Improve transparency about purpose, evidence, and reasoning
Many UM decisions are experienced as arbitrary because the rationale is unclear. Even a well-reasoned and evidence-based decision can feel illegitimate if the patient or clinician cannot understand what standard was applied.
Some transparency requirements — such as providing appeal pathways — are already formal obligations. The more important question is whether the explanation is specific enough to be actionable: Does it state clearly what rule or evidence standard was applied, and why this particular request did or did not meet it? That specificity distinguishes a decision from a black box.
3. Use technology to reduce avoidable administrative friction (carefully)
Technology matters not only because it can speed processing, but because it can change how a denial is experienced. Some organizations are deploying “smart” prior authorization tools, structured electronic submissions, and AI-assisted review of medical records or documentation.
Used well, technology can reduce repetitive effort, improve consistency, and make explanations clearer — changing how a denial is perceived, not just how fast it arrives. Used poorly, it can increase opacity and intensify the sense that decisions are arbitrary and capricious.
The design standard should be simple: Technology should reduce avoidable friction without weakening transparency, clinical review quality, or accountability.
4. Strengthen procedural fairness, especially where judgment is contested
People are often more willing to accept an unfavorable decision if they believe the process was fair. This is the idea of procedural justice: Fair procedures can increase perceived legitimacy, even when outcomes are contested.
In UM, this is not just about checking the boxes. It is about whether the process works in a way that participants experience as meaningful and fair. That can include access to a qualified reviewer with relevant expertise, a genuine opportunity to submit additional clinical information, clear explanations tied to evidence-based criteria, and appeal and peer-to-peer pathways that are timely enough to matter for care.
Procedural fairness is especially important because UM decisions often occur under time pressure and clinical uncertainty. A process that is formally compliant but slow, inaccessible, or poorly explained can still generate legitimate anger even when the final decision is reasonable.
This effect is compounded when the process has been unusually burdensome. A denial after repeated documentation requests, callbacks, and authorization delays is often experienced very differently than a prompt denial with a clear rationale, even when the underlying decision is identical. Part of the reason is simple: Once people have invested substantial time and effort, an unfavorable outcome is more likely to feel not only disappointing but wasteful. Reducing process burden is not only an efficiency goal; it is a fairness perception goal.
Beyond rational
The friction in utilization management is not simply a technical failure, and it is not simply a public-relations problem. It reflects a deeper tension: A system designed to manage shared resources must sometimes say no, while patients, caregivers, and clinicians experience care decisions as immediate, personal, and emotionally charged.
A system that always says yes is not sustainable. But a system that says no without transparency, evidence-based reasoning, timely review, or respect will predictably intensify the negative reaction to that decision. The challenge is not eliminating “no” from a system built on shared limits; it is saying “no” with care.
No Comments